Akèy › Enfeksyon COVID-19 ak Koronaviris › Alabama
Etid klinik pou Enfeksyon COVID-19 ak Koronaviris nan Alabama
3 etid pou Enfeksyon COVID-19 ak Koronaviris ap chèche patisipan nan sit nan Alabama.
Tèks ofisyèl etid la (Anglè)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Birmingham
- Research Site, Mobile
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT05624450A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- University of Alabama at Birmingham, Huntsville Regional Medical Campus (HRMC), Huntsville
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06679140Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure
- University of South Alabama, Mobile
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou May 28, 2021 · NCT04445285Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.